Access

Textsize

  • Textsize Middle
  • Textsize Large
Contact Us

EN

検索

JP

Menu

閉じる

Neurosurgery

Subject Neurosurgery
Staff
Professor: Naoya Hashimoto
Associate Professor: Hiroyasu Sasajima
Lecturer: Kazunori Tatsuzawa,Yoshinobu Takahashi
Assistant Professor: Masataka Nanto, Takumi Yamanaka,
Hayato takeuchi,Daisuke Umebayashi
 
Research Contents
Neurosurgery involves surgical treatment of nervous system disorder, whether central or peripheral nervous system. The disorder includes brain tumors, cerebrovascular diseases, head injuries, malformation, and brain dysfunction, which lead to decreased performance status and threaten life of neurosurgical patients. Surgical treatments accomplish benefits over disadvantage on the basis and rationale of nervous system characteristics and specificity. As new technology and apparatus evolve, neurosurgery aims at attaining less invasive and maximum benefits. On-going research topics contain multifactorial diagnosis and multimodal treatments as follows:
  1. Multiple aspects of brain dysfunction, plasticity, and regeneration
  2. Molecule-based optimum treatment in cerebrovascular diseases
  3. Cerebral blood flow and metabolism in intravascular neurosurgery
  4. Molecular and genetic targeting in brain tumor therapy
  5. Less invasive surgical approach in deep seated brain lesions
  6. Acute pathogenesis and tailor-made treatment in brain injuries
  7. Pathogenesis and repair mechanism in brain dysfunction diseases
Achievements
 2018年
  1. Hirata T, Kinoshita M, Tamari K, Seo Y, Suzuki O, Wakai N, Achiha T, Umehara T, Arita H, Kagawa N, Kanemura Y, Shimosegawa E, Hashimoto N, Hatazawa J, Kishima H, Teshima T, Ogawa K. 11C-methionine-18F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy. J Neurosurg. 2018 Sep 21:1-11.
  2. Goto Y, Sasajima H, Furuno Y, Kawabe T, Ohwada K, Yamanaka T, Tatsuzawa K, Hashimoto N. Unusual presentations of pediatric skull hemangiomas: report of two cases. World Neirosurg. 2018 Jul 31. Pii: S1878-8750(18)31681-4.
  3. Kayama T, Sato S, Sakurada K, Mizusawa J, Nishikawa R, Narita Y, Sumi M, Miyakita Y, Kumabe T, Sonoda Y, Arakawa Y, Miyamoto S, Beppu T, Sugiyama K, Nakamura H, Nagane M, Nakasu Y, Hashimoto N, Terasaki M, Matsumura A, Ishikawa E, Wakabayashi T, Iwadate Y, Ohue S, Kobayashi H, Kinoshita M, Asano K, Mukasa A, Tanaka K, Asai A, Nakamura H, Abe T, Muragaki Y, Iwasaki K, Aoki T, Watanabe T, Sasaki H, Izumoto S, Mizoguchi M, Matsuo T, Takeshima H, Hayashi M, Jokura H, Mizowaki T, Shimizu E, Shirato H, Tago M, Katayama H, Fukuda H, Shibui S, and Japan Clinical Oncology Group.Effects of Surgery With Salvage Stereotactic Radiosurgery Versus Surgery With Whole-Brain Radiation Therapy in Patients With One to Four Brain Metastases (JCOG0504): A Phase III, Noninferiority, Randomized Controlled Trial. J Clin Oncol. 2018 Jun 20: JCO2018786186.
  4. Takano K, Kinoshita M, Arita H, Okita Y, Chiba Y, Kagawa N, Watanabe Y, Shimosegawa E, Hatazawa J, Hashimoto N, Fujimoto Y, Kishima H. Influence of region-of-interest designs on quantitative measurement of multimodal imaging of MRnon-enhancing gliomas. Oncol Lett. 2018 May;15(5):7934-7940.
  5. Wakabayashi T, Natsume A, Mizusawa J, Katayama H, Fukuda H, Sumi M, Nishikawa R, Narita Y, Muragaki Y, Maruyama T, Ito T, Beppu T, Nakamura H, Kayama T, Sato S, Nagane M, Mishima K, Nakasu Y, Kurisu K, Yamasaki F, Sugiyama K, Onishi T, Iwadate Y, Terasaki M, Kobayashi H, Matsumura A, Ishikawa E, Sasaki H, Mukasa A, Matsuo T, Hirano H, KUmabe T, Shinoura N, Hashimoto N, Aoki T, Asai A, Abe T, Yoshino A, Arakawa Y, Asano K, Yoshimoto K, Shinobui S: JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma. J Neurooncol. 2018 Mar 20.[Epub ahead of print]
  6. Takahashi Y, Nishio A, Yamamoto D, Kamada H, Hashimoto N: Usefulness of 18F-fluorodeoxyglucose-Positron Emission Tomography in Comparison with Methionine-Positron Emission Tomography in Differentiating Solid Hemangioblastoma from Aduly Cerebellar Tumors. World Neurosurg. 2018 Feb;110:e648-e652.
 
2017年
  1. Hirayama R, Kinoshita M, Arita H, Kagawa N, Kishima H, Hashimoto N, Fujimoto Y, Yoshimine T. Voxel-based lesion mapping of meningioma: a comprehensive lesion location mapping of 260 lesions. J Neurosurg. 2017 Sep 1:1-6. 
  2. Wakabayashi T, Iuchi T, Tsuyuguchi N, Nishikawa R, Arakawa Y, Sasayama T, Miyake K, Narita Y, Hashimoto N, Okuda O, Matsuda H, Kubota K, Ito K, Nakazato Y, Kubomura K. Diagnostic Performance and Safety of Positron Emission Tomography Using (18)F-Fluciclovine in Patients with Clinically Suspected High- or Low-grade Gliomas: A Multicenter Phase IIb Trial. Asia Ocean J Nucl Med Biol. 2017 Winter ;5(1):10-21
  3. Takahashi Y, Sawada T, Akahane T, Kawase Y, Ikeda H, Makino K, Nakamura H, Hide T, Yano S, Hashimoto N, Kamada H. Monocyte chemoattractant protein 1 expression and proliferation in primary central nervous system lymphoma. Oncol Lett. 2017 Jul;14(1):264-270.
  4. Goto Y, Furuno Y, Kawabe T, Ohwada K, Tatsuzawa K, Sasajima H, Hashimoto N. Treatment of a skull-base giant cell tumor with endoscopic endonasal resection and denosumab: case report. J Neurosurg. 2017 Feb;126(2):431-434.
 
2016年
  1. Takashima S, Oka Y, Fujiki F, Morimoto S, Nakajima H, Nakae Y, Nakata S, Hosen N, Tatsumi N, Mizuguchi K, Hashimoto N, Oji Y, Tsuboi A, Kumanogoh A, Sugiyama H. Syndecan-4 as a biomarker to predict clinical outcome for glioblastoma multiforme treated with WT1 peptide vaccine. Future Sci OA. 2016 Oct 3;2(4):FSO96.
  2. Kawabe T, Yamamoto M, Sato Y, Yomo S, Kondoh T, Nagano O, Serizawa T, Tsugawa T, Okamoto H, Akabane A, Aita K, Sato M, Jokura H, Kawagishi J, Shuto T, Kawai H, Moriki A, Kenai H, Iwai Y, Gondo M, Hasegawa T, Yasuda S, Kikuchi Y, Nagatomo Y, Watanabe S, Hashimoto N. Gamma Knife radiosurgery for brain metastases from pulmonary large cell neuroendocrine carcinoma: a Japanese multi-institutional cooperative study(JLGK1401). J Neurosurg. 2016 Dec;125(Suppl 1):11-17.
  3. Kinoshita M, Sakai M, Arita H, Shofuda T, Chiba Y, Kagawa N, Watanabe Y, Hashimoto N, Fujimoto Y, Yoshimine T, Nakanishi K, Kanemura Y. Introduction of High Throughput Magnetic Resonance T2-Weighted Image Texture Analysis for WHO Grade 2 and 3 Gliomas. PLoS One. 2016 Oct 7;11(10):e0164268.
  4. Kijima N, Hashimoto N, Chiba Y, Fujimoto Y, Sugiyama H, Yoshimine T. Functional Roles of Wilms’ Tumor 1(WT1) in Malignant Brain Tumors. Codon Publications; 2016 Mar. Capter15.
  5. Oji Y, Hashimoto N, Tsuboi A, Murakami Y, Iwai M, Kagawa N, Chiba Y, Izumoto S, Elisseeva O, Ichinohasama R, Sakamoto J, Morita S, Nakajima H, Takashima S, Nakase Y, Nakata J, Kawakami M, Nishida S, Hosen N, Fujiki F, Morimoto S, Adachi M, Iwamoto M, Oka Y, Yoshimine T, Sugiyama H.Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide. Int J Cancer. 2016 Sep; 139(6): 1391-401.
  6. Hashimoto N. Cancer Immunotherapy for Gliomas: Overview and Future Directions. Neurol Med Chir (Tokyo). 2016 Jul 15;56(7):355-60.
  7. Hino A, Oka H, Hashimoto Y, Echigo T, Koseki H, Fujii A, Katsumori T, Shiomi N, Nozaki K, Arima H, Hashimoto N. Direct Microsurgical Embolectomy for Acute Occlusion of the Internal Carotid Artery and Middle Cerebral Artery. World Neurosurg. 2016 Apr ;88:243-51.
  8. Kinoshita M, Arita H, Okita Y, Kagawa N, Kishima H, Hashimoto N, Tanaka H, Watanabe Y, Shimosegawa E, Hatazawa J, Fujimoto Y, Yoshimine T. Comparison of diffusion tensor imaging and (11)C-methionine positron emission tomography for reliable prediction of tumor cell density in gliomas. J Neurosurg. 2016 Nov ;125(5):1136-1142.
  9. Arita H, Yamasaki K, Matsushita Y, Nakamura T, Shimokawa A, Takami H, Tanaka S, Mukasa A, Shirahata M, Shimizu S, Suzuki K, Saito K, Kobayashi K, Higuchi F, Uzuka T, Otani R, Tamura K, Sumita K, Ohno M, Miyazaki Y, Kagawa N, Hashimoto N, Hatae R, Yoshimoto K, Shinojima N, Nakamura H, Kanemura Y, Okita Y, Kinoshita M, Ishibashi K, Shofuda T, Kodama Y, Mori K, Tomogane Y, Fukai J, Fujita K, Terakawa Y, Tsuyuguchi N, Moriuchi S, Nonaka M, Suzuki H, Shibuya M, Maehara T, Saito N, Nagane M, Kawahara N, Ueki K, Yoshimine T, Miyaoka E, Nishikawa R, Komori T, Narita Y, Ichimura K. A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas. Acta Neuropathol Commun. 2016 Aug 8; 4(1): 79.
  10. Takano K, Kinoshita M, Takagaki M, Sakai M, Tateishi S, Achiha T, Hirayama R, Nishino K, Uchida J, Kumagai T, Okami J, Kawaguchi A, Hashimoto N, Nakanishi K, Imamura F, Higashiyama M, Yoshimine T. Different spatial distributions of brain metastases from lung cancer by histological subtype and mutation status of epidermal growth factor receptor. Neuro Oncol. 2016 May ;8(5):716-24.
  11. Shiomi N, Echigo T, Hino A, Hashimoto N, Yamaki T. Criteria for CT and Initial Management of Head Injured Infants: A Review. Neurol Med Chir (Tokyo). 2016 Jul;56(7): 442-8.
  12. Thompson EM, Hielscher T, Bouffet E, Remke M, Luu B, Gururangan S, McLendon RE, Bigner DD, Lipp ES, Perreault S, Cho YJ, Grant G, Kim SK, Lee JY, Rao AAN, Giannini C, Li KKW, Ng HK, Yao Y, Kumabe T, Tominaga T, Grajkowska WA, Perek-Polnik M, Low DCY, Seow WT, Chang KTE, Mora J, Pollack IF, Hamilton RL, Leary S, Moore AS, Ingram WJ, Hallahan AR, Jouvet A, Fèvre-Montange M, Vasiljevic A, Faure-Conter C, Shofuda T, Kagawa N, Hashimoto N, Jabado N, Weil AG, Gayden T, Wataya T, Shalaby T, Grotzer M, Zitterbart K, Sterba J, Kren L, Hortobágyi T, Klekner A, László B, Pócza T, Hauser P, Schüller U, Jung S, Jang WY, French PJ, Kros JM, van Veelen MC, Massimi L, Leonard JR, Rubin JB, Vibhakar R, Chambless LB, Cooper MK, Thompson RC, Faria CC, Carvalho A, Nunes S, Pimentel J, Fan X, Muraszko KM, López-Aguilar E, Lyden D, Garzia L, Shih DJH, Kijima N, Schneider C, Adamski J, Northcott PA, Kool M, Jones DTW, Chan JA, Nikolic A, Garre ML, Van Meir EG, Osuka S, Olson JJ, Jahangiri A, Castro BA, Gupta N, Weiss WA, Moxon-Emre I, Mabbott DJ, Lassaletta A, Hawkins CE, Tabori U, Drake J, Kulkarni A, Dirks P, Rutka JT, Korshunov A, Pfister SM, Packer RJ, Ramaswamy V, Taylor MD. Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis. Lancet Oncol. 2016 Apr;17(4):484-95.
  13. Takano K, Kinoshita M, Arita H, Okita Y, Chiba Y, Kagawa N, Fujimoto Y, Kishima H, Kanemura Y, Nonaka M, Nakajima S, Shimosegawa E, Hatazawa J, Hashimoto N, Yoshimine T. Diagnostic and Prognostic Value of 11C-Methionine PET for Nonenhancing Gliomas. AJNR Am J Neuroradiol. 2016 Jan;37(1):44-50.
  14. Nakamura T, Tateishi K, Niwa T, Matsushita Y, Tamura K, Kinoshita M, Tanaka K, Fukushima S, Takami H, Arita H, Kubo A, Shuto T, Ohno M, Miyakita Y, Kocialkowski S, Sasayama T, Hashimoto N, Maehara T, Shibui S, Ushijima T, Kawahara N, Narita Y, Ichimura K. Recurrent mutations of CD79B and MYD88 are hallmark of primary central nervous system lymphomas. Neuropathol Appl Neurobaiol. 2016 Apr;42(3):279-90.
2015年
  1. Okada H, Weller M, Huang R, Finocchiaro G, Gilbert MR, Wick W, Ellingson BM, Hashimoto N, Pollack IF, Brandes AA, Franceschi E, Heroid-Mende C, Nayak L, Panigrahy A, Pope WB, Prins R, Sampson JH, Wen PY, Reardon DA. Immunotherapy response assessment in neurooncology: a report of the RANO working group. Lancet Oncol. 2015 Nov ;16(15):e534-542.
  2. Horiike H, Murata I, Iida T, Yoshihashi S, Hoashi E, Kato I, Hashimoto N, Kuri S, Oshiro S. Liquid Li based neutron source for BNCT and science application. Appl Radiat Isot. 2015 Dec;106:92-4.
  3. Hashimoto N, Tsuboi A, Kagawa N, Chiba Y, Izumoto S, Kinoshita M, Kijima N, Oka Y, Motimoto S, Nakajima H, Morita S, Sakamoto J, Nishida S, Hosen N, Oji Y, Arita N, Yoshimine T, Sugiyama H. Wilms tumor 1 peptide vaccination combined with temozolomide against newly diagnosed glioblastoma: safety and impact on immunological response. Cancer Immunol Immunother. 2015 Jun ;64(6): 707-716.
  4. Kinoshita M, Taniguchi M, Takagaki M, Seike N, Hashimoto N, Yoshimine T. Development of a non-tissue adherent neurosurgical patty and an ex vivo testing system to evaluate adherent characteristics. J Neurosurg. 2015 May ;122(5):1180-4.
  5. Tamari K, Suzuki O, Hashimoto N, Kagawa N, Fujiwara M, Sumida I, Seo Y, Isohashi F, Yoshioka Y, Yoshimine T, Ogawa K. Treatment outcomes using Cyber Knife for brain metastases from lung cancer. J Radiat Res. 2015 Jan ;56(1):151-8.
  6. Arita H, Narita Y, Yoshida A, Hashimoto N, Yoshimine T, Ichimura K. IDH1/2 mutation detection in gliomas. Brain Tumor Pathol. 2015 Apr ;32(2):79-89.
  7. Hashimoto N, Kagawa N, Arita H, Tsuboi A, Oka Y, Oji Y, Sugiyama H, Yoshimine T. III. Peptide vaccination therapy against brain tumors. Gan To Kagaku Ryoho. 2015 Jun;42(6):687-9.
  8. Furuno Y, Sasajima H. Medical comics as tools to aid in obtaining informed consent for stroke care. Medicine (Baltimore). 94(26)e1077, 2015.

 

2014年
  1. Tanaka M, Fujimoto Y, Hirayama R, Chiba Y, Hashimoto N, Yoshimine T. Clinical and radiological features of endodermal cyst of the oculomotor nerve: A case report. Br J Neurosurg. 2014 Sep;15:1-2. [Epub ahead of print]
  2. Kinoshita M, Sasayama T, Narita Y, Yamashita F, Kawaguchi A, Chiba Y, Kagawa N, Tanaka K, Kohmura E, Arita H, Okita Y, Ohno M, Miyakita Y, Shibui S, Hashimoto N, Yoshimine T. Different spatial distribution between germinal center B and non-germinal center B primary central nervous system lymphoma revealed by magnetic resonance group analysis. Neuro Oncol. 2014 May;16(5):728-734.
  3. Kijima N, Hosen N, Kagawa N, Hashimoto N, Kinoshita M, Oji Y, Sugiyama H, Yoshimine T. Wilm’s Tumor 1 is involved in tumorigenicity of glioblastoma by regulating cell proliferatuin and apoptosis. Anticancer Res. 2014 Jan;34(1):61-7.
  4. Takahashi Y, Hashimoto N, Tokoroyama H, Yamauchi S, Nakasato M, Kondo K, Nitta K, Ide W, Hashimoto I, Kamada H. Reversible Splenial Lesion in Postpartum Cerebral Angiopathy: A Case Report. J Neuroimaging. 2014 May-Jun;24(3):292-4.
  5. Furuno Y, Sasajima H, Goto Y, Taniyama I, Aita K, Owada K, Tatsuzawa K, Mineura K. Strategies to prevent positioning-related complications associated with the lateral suboccipital approach. J Neurol Surg B Skull Base. 75(1)35-40, 2014.
  6. Watanabe S, Yamamoto M, Sato Y, Kawabe T, Higuchi Y, Kasuya H, Yamamoto T, Matsumura A, Barfod BE. Stereotactic radiosurgery for brain metastases: a case-matched study comparing treatment results for patients 80 years of age or older versus patients 65-79 years of age. J Neurosurg. 121(5)1148-57, 2014.
  7. Momose T, Nariai T, Kawabe T, Inaji M, Tanaka Y, Watanabe S, Maehara T, Oda K, Ishii K, Ishiwata K, Yamamoto M. Clinical benefit of 11C methionine PET imaging as a planning modality for radiosurgery of previously irradiated recurrent brain metastases. Clin Nucl Med. 39(11)939-43, 2014.
  8. Yamamoto M, Kawabe T, Higuchi Y, Sato Y, Nariai T, Watanabe S, Barfod BE, Kasuya H. Validity of prognostic grading indices for brain metastasis patients undergoing repeat radiosurgery. World Neurosurg. 82(6)1242-9, 2014.
  9. Yamamoto M, Kawabe T, Sato Y, Higuchi Y, Nariai T, Watanabe S, Kasuya H. Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors. J Neurosurg. 121(Suppl)16-25, 2014.
 
2013年
  1. Morimoto M, Yoshioka Y, Kotsuma T, Adachi K, Shiomi H, Suzuki O, Seo Y, Koizumi M, Kagawa N, Kinoshita M, Hashimoto N, Ogawa K. Hypofractionated stereotactic radiation therapy in three to five fractions for vestibular schwannoma. Jpn J Clin Oncol. 2013 Aug;43(8):805-12.
  2. Hirayama R, Fujimoto Y, Umegaki M, Kagawa N, Kinoshita M, Hashimoto N, Yoshimine T. Training to acquire psychomotor skills for endoscopic endonasal surgery using a personal webcam trainer. J Neurosurg. 2013 May;118(5):1120-1126.
  3. Nomura K, Kazui H, Tokunaga H, Hirata M, Goto T, Goto Y, Hashimoto N, Yoshimine T, Takeda M. Possible roles of the dominant uncinate fasciculus in naming objects: A case report of intraoperative electrical stimulation on a patient with a brain tumour. Behav Neurol. 2013;27(2): 229-34.
  4. Khoo HM, Kishima H, Kinoshita M, Goto Y, Kagawa N, Hashimoto N, Maruno M, Yoshimine T. Radiation-induced anaplastic ependymoma with a remarkable clinical response to temozolomide: A case report. Br J Neurosurg. 2013 Apr;27(2):259-61.
  5. Yamamoto M, Kawabe T, Higuchi Y, Sato Y, Nariai T, Barfod BE, Kasuya H, Urakawa Y. Delayed complications in patients surviving at least 3 years after stereotactic radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys. 85(1)53-60, 2013.
  6. Yamamoto M, Serizawa T, Sato Y, Kawabe T, Higuchi Y, Nagano O, Barfod BE, Ono J, Kasuya H, Urakawa Y. Validity of two recently-proposed prognostic grading indices for lung, gastro-intestinal, breast and renal cell cancer patients with radiosurgically-treated brain metastases. J Neurooncol. 111(3)327-35, 2013.
  7. Yamamoto M, Kawabe T, Sato Y, Higuchi Y, Nariai T, Barfod BE, Kasuya H, Urakawa Y. A case-matched study of stereotactic radiosurgery for patients with multiple brain metastases: comparing treatment results for 1-4 vs ≥ 5 tumors: clinical article. J Neurosurg. 118(6)1258-68, 2013.
Contact TEL:81-75-251-5541
FAX:81-75-251-5544
e-mail:nouge@koto.kpu-m.ac.jp
HP http://www.f.kpu-m.ac.jp/k/neuro/index.html

602-8566 Kyoto-shi, Kamigyo-ku Kajii-cho,
Kawaramachi-Hirokoji, JAPAN

Contact
TEL：075-251-5111
FAX：075-251-7093

Email